2The Digitalis Investigation Group (DIG) . The effect of digoxin on mortality and morbidity in patients with heart failure[J]. N Engl J Med, 1997, 336(8): 525-535.
3Hood WB, Dans AL Guyatt GH, et al. Digitalis for treatmerit of congestive heart failure in patients in sinus rhythm [J]. Cochrane Database Syst Rev, 2004, (2):CD002901.
4Saif S, Jeptha P, Yongfei Wang, et al. Association of serum digoxin concentration and outcomes in patients with heart failure[J]. JAMA, 2003, 289(7): 871-877.
5Aronow WS. Treatment of systolic and diastolic heart failure in the elderly[J]. Am Med Dir Assoc, 2006, 7(1):63-64.
6Rathore SS, Wang Y, Krtmtholz HM. Sex-based differences in the effect of digoxin for the treatment of heartfailure. [J]. N Engl J Med, 2002, 347(18): 1403-1411.
7Shlipak MG, Smith GL, Rathore SS, et al. Renal function, digoxin therapy, and heart failure outcomes:evidence from the digoxin intervention group trial [J].Am Soc Nephrol, 2004, 15(8): 2195-2203.
8Rich MW, McSherry F, Williford WO, et al. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study[J]. Am Coll Cardiol, 2001, 38(3): 806-813.
9Slatton ML, Irani WN, Hall SA, et al. Dose digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure in normal sinus rhythm. [J]. Am J Coll Cardiol, 1997,29: 1206.
10Misiaszek B, Heckman GA, Merali F, et al. Digoxin prescribing for heart failure in elderly residents of long-term care facilities[J]. Can J Cardiol, 2005, 21(3): 281-286.
